New MRI dye tested for kidney and adrenal imaging
NCT ID NCT07040865
First seen Nov 19, 2025 · Last updated Jun 12, 2026 · Updated 26 times
Summary
This study compares a new contrast agent, gadopiclenol, to the standard one used in MRI scans for people with suspicious findings in their kidneys or adrenal glands. About 104 adults will be randomly assigned to receive one of the two agents during a single MRI appointment. The goal is to see if the new agent works just as well as the standard one for highlighting these organs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUSPECT RENAL AND ADRENAL IMAGING FINDINGS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Diagnostic, Interventional and Pediatric Radiology Inselspital, University of Bern
RECRUITINGBern, 3010, Switzerland
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.